7,8-BENZOQUINOLINE
CAS230-27-3
7,8-BENZOQUINOLINE (CAS 230-27-3, C13H9N) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 230-27-3
- Formula
- C13H9N
- Mol. weight
- 179.22 g/mol
- Appearance
- off-white to brown crystalline powder
Chemical Specifications
Identifiers
| CAS number | 230-27-3 |
|---|---|
| Product name | 7,8-BENZOQUINOLINE |
| Chinese name | 7，8-苯并喹啉 |
| Synonyms | 7,8-benoz(h)quinoline |
| Chinese synonyms | 7,8-苯并喹啉; 苯并[H]喹啉; 1-萘喹啉; Α-萘喹啉; Α-萘喹啉7.8-苯并喹啉; 甲萘喹啉; 苯并[H]喹啉, 98+% |
| Molecular formula | C13H9N |
| Molecular weight | 179.22 g/mol |
| EC number | 205-937-0 |
Physical and chemical properties
| Appearance | off-white to brown crystalline powder |
|---|---|
| Melting Point | 48-50(lit.) ( ℃ ) |
| Boiling Point | 338 (719 mmHg) ( ℃ ) |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 7,8-BENZOQUINOLINE?
The CAS Registry Number of 7,8-BENZOQUINOLINE is 230-27-3. 7,8-BENZOQUINOLINE is also known as 7,8-benoz(h)quinoline.
What is the molecular formula and molecular weight of 7,8-BENZOQUINOLINE?
The molecular formula of 7,8-BENZOQUINOLINE is C13H9N, and its molecular weight is 179.22 g/mol.
How can I request a quotation for 7,8-BENZOQUINOLINE?
Send an inquiry for 7,8-BENZOQUINOLINE (CAS 230-27-3) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 7,8-BENZOQUINOLINE
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.